Thursday, 5 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Insecticides (India) Investor Presentation: Key Takeaways

Q2/H1 FY27 deck; no quarterly revenue, PAT or EBITDA disclosed. Highlights FY23–FY26 margin gains and H1 FY27 field-activity metrics.

Highlights
MarginsFY23→FY26 EBITDA margin 6.8%→10.6%; gross 23.1%→31.5%.
Demand visibilityH1 FY27: 18,000+ farmer meetings, 9,000+ field days, 10,00,000+ farmers connected.

Growth

No Q2/H1 FY27 growth figures disclosed. FY23–FY26: gross margin 23.1%→31.5%, EBITDA margin 6.8%→10.6%.

Outlook

No explicit guidance or capex plans. Upcoming Sotanala plant; Granuvia and Spinoace launched FY27.

Risks

No explicit risks disclosed; only standard forward-looking safe-harbour caveat.

Last quarter's promises, checked

Partly delivered

  • Granuvia INR20cr + Spinoace INR10cr+ FY27 sales → no product revenue disclosed (= PARTIAL)
  • Sotanala technicals by Diwali 2026 → deck still lists it as 'upcoming' (= PARTIAL)
  • Sotanala INR200cr total; maintenance capex INR30-40cr → no capex disclosed (= PARTIAL)

Missed

  • Q1: revised FY27 growth targets promised after H1 → none in current deck (= MISS)
Source

Investor Presentation filed with NSE, NSE: INSECTICID. Summary written with AI assistance from the document.

Read the document ↗

Insecticides (India) Ltd: key numbers

Share price
₹548.00
Market cap
₹1,595 Cr
Revenue (annual)
₹2,140 Cr
Net profit (annual)
₹139.4 Cr
P/E (TTM)
12.7×Sector 34.1×
Promoter holding
72.30%+0.00% QoQ
FII holding
4.44%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Insecticides (India) Ltd

All →